Profiles for drugs starting with 'n'
✉ Email this page to a colleague
US Patents and Regulatory Information for n
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pohl Boskamp | NITRO IV | nitroglycerin | INJECTABLE;INJECTION | 018672-002 | Aug 30, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sun Pharm | NIACIN | niacin | TABLET, EXTENDED RELEASE;ORAL | 200484-001 | Apr 23, 2014 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Teva | NEOTHYLLINE | dyphylline | TABLET;ORAL | 007794-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Paratek Pharms | NUZYRA | omadacycline tosylate | TABLET;ORAL | 209816-001 | Oct 2, 2018 | RX | Yes | Yes | 10,835,542 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Paratek Pharms | NUZYRA | omadacycline tosylate | POWDER;INTRAVENOUS | 209817-001 | Oct 2, 2018 | RX | Yes | Yes | 10,835,542 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Teva | NIFEDIPINE | nifedipine | CAPSULE;ORAL | 072651-001 | Feb 19, 1992 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
